None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? breast cancer patients with severe, continuous fatigue ? Fatigue severity scale > 3 ? cessation of chemotherapy at least 1 month before the trial ? no concurrent chemotherapy or radiotherapy during the trial ? voluntary participation ? who can follow-up for the duration of the study
Exclusion criteria
Exclusion criteria: ? severe anemia (platelet count 3, which means low ability of achivement ? abnormal findings in thyroid function test ? abnormal findings in liver function test or renal function test (AST (Aspartate aminotransferase) or ALT (Alanine aminotransferase) > 100 IU/L, Creatinine > 3.4 mg%), severe hepatic failure or renal failure ? patients who have blood coagulation disorder or bleeding disorder ? serious medical or psychiatric conditions which make the patient unsuitable to participate in the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Multidimensional Fatigue Inventory | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospital Anxiety and Depression Scale, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core questionnaire (EORTC QLQ-C30), EORTC QLQ-Breast cancer module(BR23) | — |
Countries
Korea, Republic of
Contacts
Daegu Catholic Univercity Medical Center